Low back pain is one of the most common health problems worldwide and a leading cause of disability. Most people will experience it at some point in their lives, and for many, it becomes a chronic condition that affects daily activities, work, and overall quality of life. One of the main underlying causes of chronic low back pain is intervertebral disc degeneration, a gradual process in which the discs between the bones of the spine begin to break down over time.
These discs act as cushions, absorbing shock and allowing the spine to move smoothly. As degeneration progresses, the discs lose hydration, structure, and strength. This can lead to reduced disc height, tears in surrounding structures, and increased stress on the spine. Over time, this damage may contribute to herniated discs, spinal instability, and persistent pain.
Current treatments for low back pain focus mainly on managing symptoms rather than repairing the underlying damage. Medications, physical therapy, and injections may provide relief, while more severe cases may require surgery. However, none of these approaches can directly reverse disc degeneration. This gap has led to growing interest in regenerative medicine, particularly stem cell therapy, as a potential way to repair damaged discs and restore function.
As part of this review, Vadalà et al. examine the rationale for regenerative stem cell therapy in intervertebral disc degeneration, along with the biological effects of stem cells following implantation within the disc environment based on preclinical evidence. The authors also evaluate current clinical findings and ongoing trials, while addressing future directions and key limitations of this emerging therapeutic approach.
Why Stem Cells Are Being Studied for Disc Degeneration
Stem cells are unique because they can both replicate themselves and develop into specialized cell types. In the context of spinal health, researchers are exploring whether stem cells can help restore the structure and function of damaged discs.
As discs degenerate, the number of healthy cells within them decreases. At the same time, the balance shifts toward tissue breakdown rather than repair. Stem cell therapy aims to reverse this imbalance by introducing new cells that can support regeneration. These cells may help rebuild tissue, release beneficial molecules that support healing, and activate the body’s own repair processes.
To reach the damaged area, stem cells are typically delivered through a minimally invasive procedure known as an intradiscal injection. This involves injecting the cells directly into the disc. While this approach allows for targeted treatment, researchers are still working to determine the safest and most effective way to deliver these therapies without causing additional damage to the disc.
How Stem Cells May Support Disc Repair
Stem cells may help improve disc health through several complementary mechanisms. One important pathway is their ability to develop into disc-like cells that produce essential structural components. In particular, they may support the production of the extracellular matrix, which gives discs their strength, flexibility, and ability to retain water.
Another key function of stem cells is their ability to support existing cells within the disc. Rather than replacing damaged cells directly, stem cells often work by releasing signaling molecules that encourage nearby cells to survive, grow, and function more effectively. These signals can also reduce harmful processes such as cell death and tissue breakdown.
Stem cells also have anti-inflammatory effects, which are especially important in degenerative disc disease. Inflammation plays a central role in disc degeneration by accelerating tissue damage and disrupting normal repair processes. By reducing inflammation and regulating immune activity, stem cells may help create an environment that is more favorable for healing.
Challenges of the Disc Environment
Although stem cell therapy shows promise, the environment inside a degenerated disc presents significant challenges. Discs have very limited blood supply, which means that oxygen and nutrients are already scarce. As degeneration progresses, conditions become even more difficult, with increased acidity, inflammation, and mechanical stress.
These harsh conditions can reduce the survival and effectiveness of transplanted stem cells. In some cases, the cells may not persist long enough to produce meaningful benefits. Researchers are actively exploring ways to improve stem cell survival, including preconditioning the cells before implantation and optimizing the timing of treatment.
Timing appears to be particularly important. Evidence suggests that stem cell therapy may be more effective in earlier stages of disc degeneration, before structural damage becomes too severe and the local environment becomes too hostile.
Clinical and Preclinical Evidence to Date
Preclinical studies, including laboratory and animal research, have provided encouraging evidence that stem cells can support disc regeneration. These studies have shown improvements in tissue structure, increased production of key matrix components, and reduced inflammation.
Early clinical studies in humans have also reported promising results. Patients receiving stem cell injections into degenerated discs have often experienced reductions in pain and improvements in function. In some cases, imaging studies have shown signs of increased disc hydration, which is an important indicator of disc health.
Importantly, most clinical studies to date have reported favorable safety profiles, with few serious adverse events. However, these studies have typically involved small numbers of patients and varying treatment methods, making it difficult to draw definitive conclusions. Larger, well-controlled trials are needed to confirm these findings and determine the most effective treatment approaches.
Current Limitations and Ongoing Questions
Despite growing interest in stem cell therapy for disc degeneration, several important questions remain. One major challenge is determining the optimal type and number of cells to use. Different sources of stem cells, such as bone marrow or adipose tissue, may behave differently in the disc environment.
Another key issue is identifying which patients are most likely to benefit. Not all low back pain is caused by disc degeneration, and even when degeneration is present, it does not always correlate with symptoms. Improving diagnostic accuracy will be essential for selecting appropriate candidates for treatment.
The Future of Regenerative Spine Care
Stem cell therapy represents a shift in how degenerative disc disease may be treated in the future. Instead of focusing only on symptom relief, this approach aims to address the underlying causes of degeneration by supporting tissue repair and restoring function.
While current evidence is promising, stem cell therapy is still in the early stages of clinical development. Ongoing research is focused on refining treatment protocols, improving cell survival, and identifying the patients most likely to benefit. Advances in related technologies, such as gene editing and biomaterials, may further enhance the effectiveness of these therapies in the future.
As more high-quality clinical trials are completed, a clearer picture will emerge of how stem cell therapy can be integrated into standard care. If these therapies continue to demonstrate safety and effectiveness, they may offer a meaningful new option for individuals living with chronic low back pain.
Advancing Regenerative Strategies for Disc Disease
Degenerative disc disease remains a major contributor to chronic low back pain and disability worldwide. Current treatments can help manage symptoms, but they do not directly repair damaged discs or stop the progression of degeneration. Stem cell therapy offers a promising new approach by targeting the underlying biological processes involved in disc breakdown.
By supporting tissue regeneration, reducing inflammation, and improving the local environment within the disc, stem cells may help restore function and reduce pain. Although important challenges remain, ongoing research continues to move the field forward. With further development and validation, stem cell therapy has the potential to transform the treatment of spinal conditions and improve quality of life for many patients.
Sources: Vadalà G, Ambrosio L, Russo F, Papalia R, Denaro V. Stem Cells and Intervertebral Disc Regeneration Overview-What They Can and Can’t Do. Int J Spine Surg. 2021 Apr;15(s1):40-53. doi: 10.14444/8054. Epub 2021 Apr 21. PMID: 34376495; PMCID: PMC8092931.